FWDI

Forward Industries, Inc. - 10-Q Summary (Period Ended June 30, 2012)

Business Context and Reporting Period

Forward Industries, Inc. designs, markets, and distributes carry and protective solutions for handheld electronic devices, primarily serving Original Equipment Manufacturers (OEMs). The reporting period covers the three and nine months ended June 30, 2012. On June 21, 2012, the Company announced a strategic decision to exit its global retail business (classified as discontinued operations) to focus exclusively on its OEM segment. The Company sources products from independent suppliers in China and operates in the Americas, EMEA, and APAC regions.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales from continuing operations increased 25% ($1.5 million) for the quarter and 17% ($2.9 million) for the nine-month period compared to the prior year, driven primarily by a 41% increase in Diabetic Products sales.
• Margin Compression: Gross profit margins declined significantly. For the quarter, margins dropped from 23% to 10%. This was caused by price concessions on long-lived programs, higher material/labor costs from suppliers, and significant quality remediation charges.
• Discontinued Operations: The exit of the retail business resulted in a substantial loss of $2.68 million for the quarter, including $0.87 million in inventory write-downs and $0.68 million in sales returns/price protection.
• Operating Expenses: Selling expenses decreased 58% due to restructuring and headcount reductions. General and administrative expenses decreased 14% for the quarter but increased 15% for the nine-month period due to higher professional fees and executive compensation.

Guidance, Outlook, and Risks

• Restructuring: The Company is closing offices in Santa Monica, London, Dubai, and Saarbrucken, and re-establishing headquarters in Florida to reduce costs. A new sourcing agreement with Seaton Global Corporation is being implemented to lower costs and improve quality.
• Future Losses: Management anticipates an additional loss of approximately $1.3 million from discontinued operations to be incurred in the fiscal quarter ending September 30, 2012, upon the completion of the retail exit.
• Liquidity: The Company has no debt and maintains a current ratio of 2.9. Management believes existing cash resources are adequate for the next 12 months.
• Risks: Key risks include high customer concentration (particularly in Diabetic Products), pricing pressure from major customers, inability to pass on rising supplier costs, and ongoing litigation with Targus Group International regarding alleged breach of contract and unfair competition.

Investor Verification Checklist

• Discontinued Operations Exit: Verify the timeline and final costs associated with the wind-down of the retail business, specifically the anticipated $1.3 million additional loss.
• Gross Margin Sustainability: Assess whether the 10% gross margin in the quarter is a temporary anomaly due to one-time quality charges or a structural shift due to pricing pressure and supplier costs.
• Customer Concentration: Review the dependency on major Diabetic Product customers (Customer A, B, C, and D) and the impact of price concessions on future profitability.
• Legal Proceedings: Monitor the status of the Targus Group International lawsuit, as damages are unspecified and could be material.
• Inventory Levels: Confirm the adequacy of inventory reserves given the recent write-downs in the retail segment and the shift in product mix.